Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute discusses how immunotherapy is being integrated into existing treatments for patients with gastrointestinal cancer at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Immunotherapy for GI Cancer Patients
